Washington, D.C. – Today, House Judiciary Committee Chairman Jerrold Nadler (D-NY) delivered the following opening remarks during a Subcommittee on Courts, Intellectual Property, and the Internet hearing on oversight of the U.S. Patent and Trademark Office: “Mr. Chairman, today’s hearing focuses on what has been a time of great change to our innovation landscape. In 2011, we passed the most signif... Read More »

Washington, D.C. – Today, House Judiciary Committee Chairman Jerrold Nadler (D-NY) delivered the following opening remarks during a markup of a committee report and resolution recommending that the U.S. House of Representatives find Attorney General William Barr in contempt for refusal to comply with a subpoena duly issued by the Committee on the Judiciary for the full, unredacted Mueller report: ... Read More »

Washington, D.C. – House Judiciary Committee Chairman Jerrold Nadler (D-NY) released the following statement in response to the Department of Justice’s (DOJ) letter declining the Committee’s counteroffer to view hidden sections of Special Counsel Mueller’s report. “Tonight, in the middle of good faith negotiations with the Attorney General, the Department abruptly announced that it would instead a... Read More »

Washington, D.C. –Today, House Judiciary Chairman Jerrold Nadler (D-NY) sent a letterto former White House Counsel Donald F. McGahn II responding to his failure to comply with a subpoena for documents related to the Committee's ongoing investigation into obstruction of justice, public corruption and other abuses of power by President Trump, his associates and members of his Administration. Having... Read More »

Washington, D.C. – House Judiciary Committee Chairman Jerrold Nadler (D-NY) released the following statement in response to the Department of Justice’s (DOJ) request to meet on Wednesday, the day the Committee is scheduled to markup a contempt citation for Attorney General William Barr’s failure to comply with a subpoena for the full, unredacted Mueller report: “I am pleased that the Department of... Read More »

Washington, D.C. – Today, House Judiciary Committee Chairman Jerrold Nadler (D-NY) sent a letter to Attorney General William Barr with a counter offer to immediately gain access to the redacted portions of Special Counsel Mueller’s report and underlying materials. In the Judiciary Committee Counter Offer: Nadler requests that the Department reconsider its refusal to allow all Members of Congress a... Read More »

Houston, TX– Today, House Judiciary Committee Chairman Jerrold Nadler (D-NY) delivered the following opening remarks during a Subcommittee on the Constitution, Civil Rights, and Civil Liberties field hearing on voting rights in Houston, Texas: “Thank you, Chairman Cohen, for calling this important field hearing. The Voting Rights Act of 1965 is considered by most civil rights advocates the most ef... Read More »

Washington, D.C. – House Judiciary Committee Chairman Jerrold Nadler (D-NY) delivered the following opening remarks today at a hearing where Attorney General William Barr refused to testify: “Attorney General Barr has informed us that he will not appear today. Although we worked to accommodate his concerns, he objects to the prospect of answering questions by staff counsel and to the possibility t... Read More »

Demanding the Full, Unredacted Special Counsel Report WATCH: Click here to watch Rep. Nadler discuss the House Judiciary Committee's demands for the full, unredacted Special Counsel report. Even in its redacted form, the final report issued by Special Counsel Robert Mueller outlines what I see as disturbing evidence that the President and his associates engaged in obstruction of justice and other... Read More »

Washington, D.C. – Today, House Judiciary Chairman Jerrold Nadler (D-NY) delivered the following opening statement, as prepared, for the markup on the motion to permit Committee staff to question Attorney General William Barr following the end of Member questioning at tomorrow's oversight hearing of the Department of Justice: "This motion is similar to my previous motion, differing only in that i... Read More »

Washington, D.C. – Today, House Judiciary Chairman Jerrold Nadler (D-NY) delivered the following opening remarks for the first ever markup of H.R. 5, the Equality Act, which explicitly prohibits discrimination against the LGBTQ community: “Today, the Judiciary Committee considers H.R. 5, the ‘Equality Act.’ This is long-overdue legislation that will explicitly prohibit discrimination against lesb... Read More »

Washington, D.C. – Today, House Judiciary Chairman Jerrold Nadler (D-NY) delivered the following opening remarks during a Subcommittee on Constitution, Civil Rights and Civil Liberties hearing on the Equal Rights Amendment: "Thank you Chairman Cohen for convening this critical hearing. "The first version of the Equal Rights Amendment was proposed nearly one hundred years ago by Alice Paul, who he... Read More »

Washington, D.C. –Today, House Judiciary Committee Chairman Jerrold Nadler (D-NY) delivered the following opening statement for the markup of H.R. 2375, the Preserve Access to Affordable Generics and Biosimilars Act: “H.R. 2375, the ‘Preserve Access to Affordable Generics and Biosimilars Act’ is one of a series of bipartisan measures that we are considering today to address the critical need to lo... Read More »

Washington, D.C. –Today, House Judiciary Committee Chairman Jerrold Nadler (D-NY) delivered the following opening statement for the markup of H.R. 965, the Creating and Restoring Equal Access to Equivalent Samples Act of 2019 (CREATES Act): “H.R. 965, the ‘Creating and Restoring Equal Access to Equivalent Samples Act of 2019,’ or the ‘CREATES Act,’ is bipartisan legislation that would substantiall... Read More »

Washington, D.C. –Today, House Judiciary Committee Chairman Jerrold Nadler (D-NY) delivered the following opening statement for the markup of H.R. 2374, the Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act (Stop STALLING Act): “H.R. 2374, the ‘Stop STALLING Act,’ takes an important step toward lowering drug prices and increasing competition in health care ... Read More »